Endosense Completes Enrollment In EFFICAS I Clinical Study

Links shared publicly online about this topic.

  • 497
    total visits

Endosense Completes Enrollment In EFFICAS I Clinical Study

medicalnewstoday.com —

Endosense, a Swiss medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias, has announced enrollment co

View full resource at medicalnewstoday.com

Tags: Heart, Heart Disease, Arrhythmia, Safety, Medical, Medical Technology

  • Share

Most Recently Shared on February 18, 2011 at 3:05 pm By:

mnt_heart MNT Heart News

Endosense Completes Enrollment In EFFICAS I Clinical Study http://mnt.to/3Rjg #heart #heartdisease

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Cardiovascular MNT Cardiovascular

Advertisement